Announcements Trials
Browse Landscape

Phase

Phase 2 4Phase 2/3 2Phase 1/2 2Phase 1 2

Status

Recruiting 7Completed 6Active not recruiting 4Unknown 2Terminated 2Suspended 2Withdrawn 1

Sponsor Class

OTHER 1NIH 1

Study Type

Interventional 2

Sponsor

Cancer Type

Thoracic 1Gastrointestinal 1

Conditions

Lung Neoplasms 1Carcinoma, Non-Small-Cell Lung 1Carcinoma, Hepatocellular 1Adenocarcinoma of Lung 1

Interventions

Radiotherapy 2Radiation 2Nivolumab 2Magnetic Resonance Spectroscopy 2lenvatinib 1Specimen Handling 1Sorafenib 1Platinum 1Photochemotherapy 1Oxycodone 1NUC-1031 1Ketorolac 1Ketamine 1Ipilimumab 1Gemcitabine 1Folfox protocol 1Cisplatin 1CTLA-4 Antigen 1Biopsy 1Acetaminophen 11,2-diaminocyclohexaneplatinum II citrate 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 2/3 × Suspended × Nivolumab × Clear all
NCT04929041 2026-05-13

Testing the Addition of Radiation Therapy to the Usual Treatment (Immunotherapy With or Without Chemotherapy) for Advanced Stage Non-small Cell Lung Cancer Patients Who Are PD-L1 Negative

National Cancer Institute (NCI)

Phase 2/3 Suspended
427 enrolled
Thoracic

Adenocarcinoma of Lung, Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT04268888 2025-02-26

TACE-3

The Clatterbridge Cancer Centre NHS Foundation Trust

Phase 2/3 Suspended
522 enrolled
Gastrointestinal

Carcinoma, Hepatocellular

Data powered by HemOnc (CC BY 4.0) Colophon âš¡